A Study of HS-20094 in Overweight or Obese Participants
Status:
RECRUITING
Trial end date:
2026-05-29
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open-label, parallel clinical study to evaluate the bioequivalence of the HS-20094 MDV pen and AI pen in overweight or obese subjects.